Europe Regional Office

The IVI Europe Regional Office (IERO) is based in Stockholm. As IVI’s first regional office beyond its headquarters in Seoul, Republic of Korea, IERO aims to bolster the life science and global health networks in Sweden and Europe, engaging stakeholders across research centers, academia, industry, and government to identify and pursue potential areas of collaboration. Due to its regional advantage, IERO also enables more effective engagement with our collaborators in Africa, where IVI has helped build an extensive network of disease surveillance and clinical trial sites.

The establishment of IERO and its activities are made possible through the funding support from the Swedish Government of 250 million SEK over five years.

Background

Sweden has been a strong supporter of IVI and was one of the first countries to sign the IVI Establishment Agreement. The Swedish International Development Cooperation Agency (Sida) has been providing core funding to IVI since 2002.

In 2021, IVI invited proposals for the establishment of IERO. After a thorough review, and building on the existing partnership with Sweden, the IVI Board of Trustees selected Stockholm as the host location, recognizing Sweden’s world-class research infrastructure, strong commitment to global health, and vibrant life sciences industry.

On May 18, 2022, the Parliament of Sweden approved a Host Country Agreement with IVI, laying the foundation for the establishment of the European office.

The permanent IVI Europe Regional Office officially opened on May 3, 2024. The event gathered Swedish government officials, ambassadors, and key partners from IVI’s global network.

Learn more about IVI and Sweden’s partnership.

Contact

Visiting address: Berzelius väg 8, Stockholm, Sweden
Email: ivieurope@www.ivi.int